Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database

Abstract 3,4-Methylenedioxymethamphetamine (MDMA) is currently being evaluated by the Food and Drug Administration (FDA) for the treatment of post-traumatic stress disorder (PTSD). If MDMA is FDA-approved it will be important to understand what medications may pose a risk of drug–drug interactions....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Isaac V. Cohen, Tigran Makunts, Ruben Abagyan, Kelan Thomas
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b5fcb5c6d48f493398295aa1b6997412
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares